Filter Results:
- Full text PDF available (7)
Publication Year
2006
2017
- This year (0)
- Last 5 years (3)
- Last 10 years (5)
Publication Type
Co-author
Journals and Conferences
Learn More
- Ronnie C. Mease, Crystal L. Dusich, +8 authors Martin G. Pomper
- Clinical cancer research : an official journal of…
- 2008
PURPOSE
Previously, we showed successful imaging of xenografts that express the prostate-specific membrane antigen (PSMA) using small-animal positron emission tomography (PET) and the radiolabeled… (More)
- Sébastien Baechler, Robert F Hobbs, Andrew R Prideaux, Richard L. Wahl, G. Sgouros
- Medical physics
- 2008
In dosimetry-based treatment planning protocols, patients with rapid clearance of the radiopharmaceutical require a larger amount of initial activity than those with slow clearance to match the… (More)
- Andrew R Prideaux, Hong Mei Song, +5 authors G. Sgouros
- Journal of nuclear medicine : official…
- 2007
UNLABELLED
Phantom-based and patient-specific imaging-based dosimetry methodologies have traditionally yielded mean organ-absorbed doses or spatial dose distributions over tumors and normal organs.… (More)
- Hong Mei Song, Bin He, +6 authors G. Sgouros
- Journal of nuclear medicine : official…
- 2006
UNLABELLED
The lungs are the most frequent sites of distant metastasis in differentiated thyroid carcinoma. Radioiodine treatment planning for these patients is usually performed following the… (More)
- Robert F Hobbs, Sébastien Baechler, +6 authors G. Sgouros
- Physics in medicine and biology
- 2010
Whole-body (WB) planar imaging has long been one of the staple methods of dosimetry, and its quantification has been formalized by the MIRD Committee in pamphlet no 16. One of the issues not… (More)
- G. Sgouros, Eric Frey, Richard Wahl, Bin He, Andrew R Prideaux, Robert F Hobbs
- Seminars in nuclear medicine
- 2008
Targeted radionuclide therapy holds promise as a new treatment for cancer. Advances in imaging are making it possible for researchers to evaluate the spatial distribution of radioactivity in tumors… (More)
- David Mark Loeb, Elizabeth L Garrett-Mayer, +6 authors Cindy L. Schwartz
- Cancer
- 2009
BACKGROUND
Samarium-153 ethylenediaminetetramethylene phosphonic acid ((153)Sm-EDTMP) has been used to treat patients with high-risk osteosarcoma. The purpose of the current study was to determine… (More)
- Hong Mei Song, Yong Du, G. Sgouros, Andrew R Prideaux, Eric C. Frey, Richard L. Wahl
- Journal of nuclear medicine : official…
- 2007
UNLABELLED
Pulmonary involvement is common in patients with non-Hodgkin's lymphoma (NHL). (90)Y- and (131)I-anti-CD20 antibodies (ibritumomab tiuxetan and tositumomab, respectively) have been… (More)
- Sébastien Baechler, Robert F Hobbs, Andrew R Prideaux, Mélanie Recordon, Angelika Bischof-Delaloye, G. Sgouros
- Cancer biotherapy & radiopharmaceuticals
- 2008
UNLABELLED
The aim of the present study was to retrospectively estimate the absorbed dose to kidneys in 17 patients treated in clinical practice with 90Y-ibritumomab tiuxetan for non-Hodgkin's… (More)
- Donika Plyku, David Mark Loeb, +4 authors Robert F Hobbs
- Cancer biotherapy & radiopharmaceuticals
- 2015
PURPOSE
Dosimetric accuracy depends directly upon the accuracy of the activity measurements in tumors and organs. The authors present the methods and results of a retrospective tumor dosimetry… (More)